rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
13-14
|
pubmed:dateCreated |
2010-8-31
|
pubmed:abstractText |
Tumor markers analysis has been proposed as a less invasive alternative for categorizing malignant and non-malignant pleural effusions. This study establishes diagnostic cutoffs for CEA and CA19-9 in pleural fluid to differentiate etiologies of effusions.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1873-2933
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright (c) 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1051-5
|
pubmed:meshHeading |
pubmed-meshheading:20529669-CA-19-9 Antigen,
pubmed-meshheading:20529669-Carcinoembryonic Antigen,
pubmed-meshheading:20529669-Diagnostic Equipment,
pubmed-meshheading:20529669-Female,
pubmed-meshheading:20529669-Humans,
pubmed-meshheading:20529669-Male,
pubmed-meshheading:20529669-Pleural Effusion,
pubmed-meshheading:20529669-Pleural Effusion, Malignant,
pubmed-meshheading:20529669-ROC Curve,
pubmed-meshheading:20529669-Tumor Markers, Biological
|
pubmed:year |
2010
|
pubmed:articleTitle |
Performance of CEA and CA19-9 in identifying pleural effusions caused by specific malignancies.
|
pubmed:affiliation |
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
|
pubmed:publicationType |
Journal Article
|